___

• 1.Aebi H., 1984. Catalase in vitro. Meth Enzymol, 105, 121-126.
• 2.Albrahim T., Alonazi M.A., 2021. Lycopene corrects metabolic syndrome and liver injury induced by high fat diet in obese rats through antioxidant, anti-inflammatory, antifibrotic pathways. Biomed Pharmacother, 141, 111831.
• 3.Aksu E.H., Kandemir F.M., Küçükler S., 2021.Ameliorative effect of hesperidin on streptozotocin‐diabetes mellitus‐induced testicular DNA damage and sperm quality degradation in Sprague–Dawley rats. JFood Biochem, 45, 10: e13938.
• 4.AksuE.H., Kandemir, F.M., Küçükler, S., 2021. The effects of hesperidin on colistin‐induced reproductive damage, autophagy, and apoptosis by reducing oxidative stress. Andrologia, 53, e13900.
• 5.Aboubakr M., Elshafae S.M., Abdelhiee E.Y., Fadl S.E., Soliman A., Abdelkader A., Abdeen A., 2021. Antioxidant and anti-inflammatory potential of thymoquinone and lycopene mitigate the chlorpyrifos-induced toxic neuropathy. Pharmaceuticals, 14, 940.
• 6.Ateşşahin A., Şahna E., Türk G., Çeribaşi A.O., Yılmaz S., Yüce A., Bulmuş Ö., 2006. Chemoprotective effect of melatonin against cisplatin‐induced testicular toxicity in rats. J Pineal Res, 41, 21-27.
• 7.Behranvand N., Nasri F., Zolfaghari Emameh R., Khani P., Hosseini A., Garssen J., Falak R., 2021. Chemotherapy: a double-edged sword in cancer treatment. Cancer Immunol Immunother, 1-20.
• 8.Cao C., Sun S., Li J., Song C., Meng Q., Shi B., Shan A., 2021. Lycopene modulates lipid metabolism in rats and their offspring under a high-fat diet. Food Funct,12, 8960-8975.
• 9.Carvalho G.C., de Camargo B. A. F., de Araújo J. T. C., Chorilli M., 2021. Lycopene: From tomato to its nutraceutical use and its association with nanotechnology. Trends Food Sci Technol, 118, 447-458.
• 10.Celik H., Kucukler S., Ozdemir S., Comakli S., Gur C., Kandemir F. M., Yardim A., 2020. Lycopene protects against central and peripheral neuropathy by inhibiting oxaliplatin-induced ATF-6 pathway, apoptosis, inflammation and oxidative stress in brains and sciatic tissues of rats. Neurotoxicology, 80, 29-40.
• 11.Dunn T, Schmoll H, Grünwald V, Bokemeyer V, Casper JJInd., 1997. Comparative cytotoxicity of oxaliplatin and cisplatin in non-seminomatous germ cell cancer cell lines. Invest New Drugs,15: 109-14.
• 12.Elsayed A., Elkomy A., Elkammar R., YoussefG., Abdelhiee E.Y., Abdo W., Aboubakr M., 2021. Synergistic protective effects of lycopene and N-acetylcysteine against cisplatin-induced hepatorenal toxicity in rats. Sci Rep, 11, 1-10.
• 13.Famurewa A.C., Ekeleme‐Egedigwe C.A., Onwe C.S., Egedigwe U.O., Okoro C.O., Egedigwe U.J., Asogwa N.T., 2020. Ginger juice prevents cisplatin‐induced oxidative stress, endocrine imbalance and NO/iNOS/NF‐κB signalling via modulating testicular redox‐inflammatory mechanism in rats. Andrologia, 52, e13786.
• 14.Guerra A.S., Hoyos C.G., Molina-Ramírez C., Velásquez-Cock J., Vélez L., Gañán P., Zuluaga R., 2021. Extraction and preservation of lycopene: A review of the advancements offered by the value chain of nanotechnology. Trends Food Sci Technol, 116, 1120-1140.
• 15.Hellberg V, Wallin I, Eriksson S, Hernlund E, Jerremalm E, Berndtsson M, Eksborg S, Arnér S.J., Shoshan M, Ehrsson H, Laurell G., 2009. Cisplatin and oxaliplatin toxicity: importance of cochlear kinetics as a determinant for ototoxicity. J Natl Cancer Inst, 101, 37-47.
• 16.Holmes J, Stanko J, Varchenko M, Ding H, Madden VJ, Bagnell Cr, Wyrick SD, Chaney SG., 1998. Comparative neurotoxicity of oxaliplatin, cisplatin, and ormaplatin in a Wistar rat model. 46, 342-51.
• 17.Jerremalm E, Wallin I, Yachnin J, Ehrsson HJEjops., 2006. Oxaliplatin degradation in the presence of important biological sulphur-containing compounds and plasma ultrafiltrate. Eur J Pharm Biopharm, 28, 278-83.
• 18.Kandemir F.M., Caglayan C., Darendelioglu E., Kucukler S., İzol E., Kandemir Ö., 2021. Modulatory effects of carvacrol against cadmium-induced hepatotoxicity and nephrotoxicity by molecular targeting regulation. Life Sci, 277, 119610.
• 19.Kandemir F.M., Yıldırım S., Kucukler S., Caglayan C., Darendelioğlu E., Dörtbudak M.B., 2020. Protective effects of morin against acrylamide-induced hepatotoxicity and nephrotoxicity: A multi-biomarker approach." Food Chem Toxicol, 138, 111190.
• 20.Kawai Y., Nakao T., Kunimura N., Kohda Y., Gemba MJJops., 2006. Relationship of intracellular calcium and oxygen radicals to cisplatin-related renal cell injury. J Pharmacol Sci, 0601120013-13.
• 21.Küçükler S., Çomaklı S., Özdemir S., Çağlayan C., Kandemir F. M., 2021. Hesperidin protects against the chlorpyrifos‐induced chronic hepato‐renal toxicity in rats associated with oxidative stress, inflammation, apoptosis, autophagy, and up‐regulation of PARP‐1/VEGF. Environ Toxicol, 36, 1600-1617.
• 22.Lévi F., Metzger G., Massari C., Milano GJCp., 2000. Oxaliplatin. Drugs, 38, 1-21.
• 23.Li N., Wu X., Zhuang W., Xia L., Chen Y., Wu C., Zhou Y., 2021. Tomato and lycopene and multiple health outcomes: Umbrella review. Food Chem, 343, 128396.
• 24.Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J., 1951. Protein measurement with the Folin phenol reagent. J Biol Chem, 193, 265-275.
• 25.Luo F.R., Wyrick S.D., Chaney S.G., 1999. Pharmacokinetics and biotransformations of oxaliplatin in comparison with ormaplatin following a single bolus intravenous injection in rats. Cancer Chemother Pharmacol, 44, 19-28.
• 26.Mani S., Graham M.A., Bregman D.B., Ivy P., Chaney SG., 2002. Oxaliplatin: a review of evolving concepts. Cancer Invest, 20, 246-63.
• 27.Matkovics B., 1988. Determination of enzyme activity in lipid peroxidation and glutathione pathways. Laboratoriumi Diagnosztika, 15, 248-250.
• 28.Misset J., Chollet P., Vennin P., Laplaige P., Lucas V., Gamelin E., Laademet A., Otero J.,2001. Multicenter phase II—III study of oxaliplatin plus cyclophosphamide vs. cisplatin plus cyclophosphamide in chemonaive advanced ovarian cancer patients. Ann Oncol, 12, 1411-1415.
• 29.Özdemir S., KucuklerS., Çomaklı S., Kandemir F. M., 2020. The protective effect of Morin against ifosfamide-induced acute liver injury in rats associated with the inhibition of DNA damage and apoptosis. Drug Chem Toxicol, 1-10.
• 30.Placer Z.A., Cushman, L.L., Johnson B.C., 1966.Estimation of product of lipid peroxidation (malonyl dialdehyde) in biochemical systems. Anal Biochem, 16, 359-364.
• 31.Parvez S., Tabassum H., Banerjee B.D., Raisuddin S.J.B., 2008. Taurine prevents tamoxifen‐induced mitochondrial oxidative damage in mice. Basic Clin Pharmacol Toxicol, 102, 382-87.
• 32.Rao A., Agarwal S.J., 1999. Role of lycopene as antioxidant carotenoid in the prevention of chronic diseases: a review. Nutr Res Rev, 19, 305-23.
• 33.Reddy PH, Beal M.F., 2005. Are mitochondria critical in the pathogenesis of Alzheimer's disease? Brain Res Rev, 49, 618-32.
• 34.Rezvanfar M.A., Rezvanfar M.A., Shahverdi A.R., Ahmadi A., Baeeri M., Mohammadirad A., Abdollahi M., 2013. Protection of cisplatin-induced spermatotoxicity, DNA damage and chromatin abnormality by selenium nano-particles. Toxicol Appl Pharmacol, 266, 356-65.
• 35.Sadek K., Abouzed T., Nasr S.J., 2015. Lycopene modulates cholinergic dysfunction, Bcl-2/Bax balance, and antioxidant enzymes gene transcripts in monosodium glutamate (E621) induced neurotoxicity in a rat model. Can J Physiol Pharmacol, 94, 394-401.
• 36.Sandhir R., Mehrotra A., Kamboj S.S., 2010. Lycopene prevents 3-nitropropionic acid-induced mitochondrial oxidative stress and dysfunctions in nervous system. Neurochem Int, 57, 579-87.
• 37.Sedlak J., Lindsay, R. H., 1968. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal. Biochem, 25, 192-205.
• 38.Sun Y. I., Oberley L. W., Li Y., 1988. A simple method for clinical assay of superoxide dismutase. Clin Chem, 34, 497-500.
• 39.Tapiero H., Townsend D., Tew K.J.B., Pharmacotherapy., 2004. The role of carotenoids in the prevention of human pathologies. Biomed Pharmacother, 58, 100-10.
• 40.Turner T., Tung K.S., Tomomasa H., Wilson L.W., 1997. Acute testicular ischemia results in germ cell-specific apoptosis in the rat. Biol Reprod, 57, 1267-74.
• 41.Türk G., Ateşşahin A., Sönmez M., Yüce A., Çeribaşi A.O., 2007. Lycopene protects against cyclosporine A-induced testicular toxicity in rats. Theriogenology, 67, 778-85.
• 42.Velmurugan B., Santhiya S.T., Nagini S.J., 2004. Protective effect of S-allylcysteine and lycopene in combination against N-methyl-N'-nitro-N-nitrosoguanidine-induced genotoxicity. Pol J Pharmacol, 56, 241-46.
• 43.Visioli F., Riso P., Grande S., Galli C., Porrini M.J., 2003. Protective activity of tomato products on in vivo markers of lipid oxidation. Eur J Nutr, 42, 201-06.
• 44.Yucel C., Arslan F. D., Ekmekci S., Ulker V., Kisa E., Yucel E. E.,Uçar M., İlbey Y.O., Celik O., Basok B.i., Kozacioglu, Z., 2019. Protective effect of all-trans retinoic acid in cisplatin-induced testicular damage in rats. World J Mens Health, 37, 249-256.
• 45.Wang Y., Zhao H., Liu Y., Li J., Nie X., Huang P., Xing, M., 2021. Environmentally relevant concentration of sulfamethoxazole-induced oxidative stress-cascaded damages in the intestine of grass carp and the therapeutic application of exogenous lycopene. Environ Pollut, 274, 116597.
• 46.Wang Z., Fan J., Wang J., Li Y., Xiao L., Duan D., Wang Q., 2016. Protective effect of lycopene on high-fat diet-inducedcognitive impairment in rats. Neurosci Lett, 627, 185-91.